NASDAQ:BPTH

Bio-path Holdings Stock Predictions

Healthcare > Biotechnology

Buy BPTH

*Your capital is at risk

$0.0300

+0.0066 (+28.21%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

BPTH Prediction Chart

BPTH Predictions History

Latest community submissions for BPTH.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JuanC Villegas Pro	Jun 7, 2017	$0.397 -99.97%	$0.390	V	98.10%	0
bbullish2 Merchant @bbullish2.7792	Jun 7, 2017	$0.370 -99.98%	$0.390	V	95.00%	0
Jon Merchant	Jun 7, 2017	$0.391 -99.97%	$0.390	V	99.60%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BPTH with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BIO-PATH HOLDINGS

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by